(Q50700264)

17 March 2018

title

Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis. (English)

1 reference

17 March 2018

author name string

Alexandra Balbir-Gurman

1

1 reference

17 March 2018

Yolanda Braun-Moscovici

2

1 reference

17 March 2018

Vladimir Livshitz

3

1 reference

17 March 2018

Daniel Schapira

4

1 reference

17 March 2018

Doron Markovits

5

1 reference

17 March 2018

Alexander Rozin

6

1 reference

17 March 2018

Tatiana Boikaner

7

1 reference

17 March 2018

A Menahem Nahir

8

1 reference

17 March 2018

publication date

31 March 2007

1 reference

17 March 2018

published in

Clinical Rheumatology

1 reference

17 March 2018

volume

26

1 reference

17 March 2018

issue

9

1 reference

17 March 2018

page(s)

1517-1521

1 reference

17 March 2018

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-007-0613-2

The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. General features of the systems used

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-007-0613-2

Superoxide dismutase and pulmonary oxygen toxicity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-007-0613-2

Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study

21 January 2018

1 reference

12 December 2020

Monocytes of patients wiht systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion

1 reference

12 December 2020

The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis

1 reference

12 December 2020

Lipid peroxidation and trace elements in systemic sclerosis

1 reference

12 December 2020

Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma

1 reference

12 December 2020

Oxidative stress in Systemic Sclerosis

1 reference

12 December 2020

Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: evidence of free radical-mediated injury

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

12 December 2020

Role of metal-catalyzed oxidation reactions in the early pathogenesis of scleroderma.

1 reference

12 December 2020

Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels

1 reference

12 December 2020

Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon.

1 reference

12 December 2020

Effect of superoxide dismutase on bleomycin-induced dermal sclerosis: implications for the treatment of systemic sclerosis

1 reference

12 December 2020

Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients

1 reference

12 December 2020

Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis

1 reference

12 December 2020

The Role of Superoxide Anion in the Autoxidation of Epinephrine and a Simple Assay for Superoxide Dismutase

1 reference

12 December 2020

Elevated plasma superoxide dismutase activity in patients with systemic sclerosis

1 reference

12 December 2020

The effects of iloprost infusion on microcirculation is independent of nitric oxide metabolites and endothelin-1 in chronic peripheral ischaemia

1 reference

12 December 2020

Topical application of superoxide dismutase cream

1 reference

12 December 2020

Decreased plasma superoxide scavenging activity in immunological disorders — carboxyethylgermanium sesquioxide (Ge-132) as a promoter of prednisolone

1 reference

12 December 2020

Serum copper and caeruloplasmin in ankylosing spondylitis, systemic sclerosis, and morphea

1 reference

12 December 2020

Gene expression in acute myocardial stress. Induction by hypoxia, ischemia, reperfusion, hyperthermia and oxidative stress.

1 reference

12 December 2020

The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement.

1 reference

12 December 2020

Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway

1 reference

12 December 2020

A radical proposal for the pathogenesis of scleroderma

1 reference

12 December 2020

Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis.

1 reference

12 December 2020

An improved colorimetric enzymatic assay of ceruloplasmin

1 reference

12 December 2020

10.1007/S10067-007-0613-2

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018